Large Cell Neuroendocrine Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
To assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.
San Francisco, California and other locations